SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending as chatter swirls around its potential to power AI data centers with its Aurora reactors, fueled by partnerships and new projects. While some celebrate technical breakouts and potential upside, others caution about bubble territory, pointing to the company's pre-revenue status and high valuation. The community is actively debating whether the stock's surge is justified by future prospects or driven by pure speculation.

AGM Group Holdings, Inc. is a technology company, which engages in the provision of financial solutions. It focuses on the research and development of blockchain-oriented ASIC chip, production of encryption mining machines, and financial technology software services. Its products and services include technology hardware research and development, and assembling and sales of technology hardware. The company was founded by Zhen Tao Jiang and Wen Jie Tang on April 27, 2015 and is headquartered in Hong Kong.

AGM Group Holdings Inc - Ordinary Shares - Class A

AGMH is experiencing a surge, driven by a restatement regarding the sale of its Nanjing Lucun subsidiary. The community is actively discussing the stock's potential for a short squeeze given its low float and high short interest, while some express concerns about potential overextension.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum ($QBTS) is trending as investors discuss its potential amid growing interest in quantum computing and AI, with some drawing comparisons to NVDA's early days. Community members are excited about the stock's recent surge, potential partnerships, and takeover bids, while others are wary of the high valuation and insider selling. The broader context involves government initiatives and potential gamma squeezes driving interest in the quantum computing sector as a whole.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is trending as the community discusses a potential IPO and the implications for common shareholders, with speculation fueled by analyst ratings and comments from key figures like Pulte. Trading volume and price movements are being closely watched for clues about the government's plans. Some investors express concern about potential dilution while others remain optimistic about significant gains.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as traders discuss a potential short squeeze and draw comparisons to other AI defense stocks like Palantir. The community is focused on key resistance levels, anticipating a continued rally and eyeing a move towards higher price targets. Some traders speculate on upcoming news or contract announcements as potential catalysts for further growth.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is surging amid renewed interest in quantum computing, fueled by news of a recent Air Force contract and progress in DARPA's Quantum Benchmarking Initiative. The community is actively discussing potential upside targets and whether the stock is overvalued, while some traders are taking profits after recent gains. Interest in related sectors such as materials suppliers and quantum-resistant crypto are also part of the conversation.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as the company announced plans to participate in the White House's eVTOL pilot program, sparking discussions about its potential to catch up to competitor Joby Aviation. The community is weighing the significance of this move, comparing market caps and anticipating future catalysts like full EVTOL flights and defense contracts. Some traders are noting technical indicators suggesting a possible upcoming price surge.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as the CDC advisory panel reviews COVID-19 vaccine recommendations and discusses potential safety concerns with mRNA vaccines, leading some to speculate about a possible advantage for NVAX as a non-mRNA alternative. The community is actively debating the implications of the meeting and expressing frustration over the lack of media coverage differentiating Novavax from mRNA vaccines. Some investors hope that Novavax will be positioned as a safer option amid scrutiny of mRNA technology, while others remain skeptical about the company's ability to capitalize on the situation.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is trending as the community discusses its growth potential and expansion plans, evidenced by strong revenue growth and new shop openings. A potential exemption of coffee from tariffs is also fueling bullish sentiment, while some investors express concerns about valuation and potential pullbacks. Overall, the conversation revolves around whether BROS can sustain its momentum in a competitive market.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBT is trending amid broader discussions about the quantum computing sector, with community members highlighting its potential breakout and comparing it to other companies like IONQ and RGTI. Some traders are expressing bullish sentiment based on technical indicators and CEO actions, while others remain skeptical, citing concerns about valuation and profitability. The stock's movement is also being attributed to sector-wide momentum and speculation about AI money flowing into quantum computing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Novavax (NVAX) Fell More Than Broader Market

Novavax (NVAX) closed at $8.39 in the latest trading session, marking a -1.99% move from the prior day.

MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response

Moderna jumps after its updated formulation of Spikevax shows an over 8-fold increase in neutralizing antibodies against the LP.8.1 COVID-19 variant in phase IV study.

COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths

MRNA, BNTX, PFE and NVAX stocks fall as health officials reportedly plan to link COVID-19 vaccines to child deaths ahead of a key CDC meeting.

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know  

Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Novavax, Inc. (NVAX) announced on Thursday that its COVID-19 vaccine, Nuvaxovid, has been approved in Japan, triggering a milestone payment from Japanese pharmaceutical company Takeda.The vaccine was approved for initial immunization (first and second vaccinations) in individuals aged six years or older, and as a booster immunization (following the third vaccination) in individuals aged 12 years or older in the country.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/NVAX">NVAX stock</a> stayed within ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.Under Novavax’s <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.novavax.com/press-releases/2025-09-04-Nuvaxovid-R-Now-Approved-in-Japan-Triggering-Takeda-Milestone-Payment">deal</a> with Takeda, the company is also eligible to receive royalties on net sales of Nuvaxovid from Takeda in this vaccination season. The company did not disclose specific payment amounts, saying that it is bound by contractual confidentiality agreements.Novavax and Takeda updated the terms of their 2020 collaboration and licensing agreement for Nuvaxovid in May. The amended deal includes an upfront payment, a payment related to the 2024-2025 season, annual milestones associated with regulatory approvals, and royalties on net sales earned every season moving forward, the company stated. In the second quarter, the company reported $27 in licensing, royalties, and other revenue from Takeda.Novavax got the U.S. Food and Drug Administration’s approval for Nuvaxovid in May for the prevention of COVID-19 in adults 65 years and older and individuals aged 12 through 64 years who have at least one underlying condition that puts them at high risk for severe outcomes from the disease. The FDA then requested the company to conduct a postmarketing commitment (PMC) study.However, Novavax <a href="https://stocktwits.com/news-articles/markets/equity/novavax-cfo-says-sanofi-to-cover-majority-of-future-nuvaxovid-study-costs/chrScEpRd50">stated</a> last month that the study will not impact its operating profit for 2025, as its partner, Sanofi, will cover the majority of the expenses.NVAX stock is down 9% this year and approximately 38% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/this-burger-chain-stock-has-gained-9-this-year-bmo-capital-sees-another-14-upside/chwdEPGRdYl">This Burger Chain Stock Has Gained 9% This Year And BMO Capital Sees Another 14% Upside – Find Out More</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a medical syringe is displayed on a screen, and the logo of Novavax in the background. (Photo Illustration by Nikos Pekiaridis/SOPA Images/LightRocket via Getty Images)

Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda

The vaccine was approved for initial immunization in individuals aged six years or older and as a booster immunization in those aged 12 years or older in the country. 

Equity

The vaccine was approved for initial immunization in individuals aged six years or older and as a booster immunization in those aged 12 years or older in the country. 


Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day

Boyd Gaming surges on strong earnings and growth plans, while Shoe Carnival struggles with sliding sales and weaker momentum.

FDA Approves Updated COVID-19 Vaccines but With Restrictions

FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups.

Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

U.S. Health Secretary Robert F. Kennedy Jr. stated on Wednesday that the Food and Drug Administration (FDA) has now granted full marketing authorization for certain&nbsp;Covid&nbsp;vaccines targeting higher-risk groups.&nbsp;The health secretary said that the decision marks a transition away from pandemic-era emergency powers. “The American people demanded science, safety, and common sense. This framework delivers all three,” the secretary said, adding thanks to FDA official Dr. Marty Makary for his role in the process.Moderna’s (MRNA) shot has been authorized for individuals six months and older, Pfizer's (PFE) for ages five and up, and Novavax's (NVAX) for ages 12 and above. In a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/SecKennedy/status/1960742897201872969">post</a> on X, Kennedy stated that these will be available to patients who choose vaccination, in consultation with their doctors.&nbsp;<figure class="image"><img style="aspect-ratio:1080/1907;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_27_22_13_10_04_0b2fce7a16bf2b728d6ffa28c8d60efb_1_jpg_d5715c25ca.webp" alt="Screenshot_2025-08-27-22-13-10-04_0b2fce7a16bf2b728d6ffa28c8d60efb (1).jpg" width="1080" height="1907"><figcaption>Source: @SecKennedy/X</figcaption></figure>The news comes on the heels of a Daily Beast&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.thedailybeast.com/donald-trump-and-robert-f-kennedy-junior-to-ban-covid-19-vaccine-within-months/">report</a> which stated that "a decision to remove the (COVID-19) vaccine from the U.S. market pending further research will come ‘within months,’" citing British cardiologist Dr. Aseem Malhotra.&nbsp;<a href="http://stocktwits.com/symbol/MRNA">Modern’s stock</a> edged 0.5% higher in afternoon trade with retail sentiment around the company moving higher within ‘extremely bullish’ territory over the past day.&nbsp;<a href="http://stocktwits.com/symbol/PFE">Pfizer’s stock</a> moved 0.4% higher, but retail sentiment continued to trend in the ‘neutral’ zone.&nbsp;<a href="http://stocktwits.com/symbol/NVAX">Novavax’s stock</a> was among the top trending stocks on the platform, but its price fell 0.5% and retail sentiment dipped to ‘neutral’ from the ‘bullish’ zone. The stock has fallen by more than 8% over the past week following the company's&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/novavax-stock-suffers-sharpest-drop-in-months-after-225-m-debt-deal-retail-still-leans-bullish/chsmrNiRd0d">announcement</a> of its new debt refinancing plan.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/warner-bros-names-brad-singer-cfo-ahead-of-planned-spinoff/chsUE1pRdlI">Warner Bros. Names Brad Singer CFO Ahead Of Planned Spinoff</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Health and Human Services Secretary Robert F. Kennedy Jr. speaks during a cabinet meeting with U.S. President Donald Trump on August 26, 2025 in Washington, DC. (Photo by Chip Somodevilla/Getty Images)

Robert Kennedy Jr. Announces End Of FDA Covid Mandates – Clears Moderna, Pfizer, Novavax For High-Risk Groups

Moderna’s Covid vaccine has been authorized for individuals six months and older, Pfizer's for ages five and up, and Novavax's for ages 12 and above. 

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Current Price	$8.71
Prev Close	$8.53
Open	$8.55
Dividend Yield	0.00%
50-Day Moving Average	$7.76
Beta	1.68
Avg. Volume	9.25M
PE Ratio	3.78

52-Week High	$15.22
52-Week Low	$5.01
Market Capitalization	$1.39B
EPS (Annual)	-$1.23
Price to Book	36.76
Revenue Per Employee	$716,556.72
Enterprise Value/EBITDA	N/A

NVAX
Novavax Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NVAX News

NVAX Novavax Inc